COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, the U.S. Food and Drug Administration's (FDA) staff reviewers said on Monday. Reuters Reuters

...

The comments were made in documents posted ahead of Thursday's meeting of a panel of FDA's independent experts, who are expected to make recommendations on what strain an updated COVID-19 booster should target.

...